Evidence map›Paper›PMID 35031980›Full record

ArticleThe protein journal2022

Molecular Cloning, Expression and Characterisation of a Bacterial Myrosinase from Citrobacter Wye1.

Fatma Cebeci, Melinda J Mayer, John T Rossiter, Richard Mithen, Arjan Narbad

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Fatma CebeciFood Innovation and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich, UK. fatmacebeci@bayburt.edu.tr.ORCID 0000-0003-4715-6689
Melinda J MayerGut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich, UK.
John T RossiterDepartment of Life Sciences, Imperial College London, London, UK.
Richard MithenFood Innovation and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich, UK.
Arjan NarbadFood Innovation and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich, UK.
Quadram Institute · GBBayburt University · TRImperial College London · GBUniversity of Auckland · NZ

Funding

Biotechnology and Biological Sciences Research Council BB/J004529/1Biotechnology and Biological Sciences Research Council BB/J004545/1Biotechnology and Biological Sciences Research Council BB/R012490/1Biotechnology and Biological Sciences Research Council BB/R012512/1Biotechnology and Biological Sciences Research Council BBS/E/F/00044437Biotechnology and Biological Sciences Research Council BBS/E/F/00044453Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Biotechnology and Biological Sciences Research Council BBS/OS/GC/000010B
6 · The paper itself

Abstract

Glucosinolates are plant natural products which on degradation by myrosinases give rise to the beneficial bioactive isothiocyanates. Recently, a myrosinase activity was detected in a Citrobacter strain isolated from soil. This enzyme was purified enabling its amino acid sequence and gene sequence (cmyr) to be determined. In order to study this myrosinase it was necessary to establish an expression system that would enable future work such as a structural determination of the protein to be carried out. The myrosinase gene was amplified, cloned and expressed in Escherichia coli with a 6XHis-tag. The heterologous expression of cmyr enabled relatively large amounts of myrosinase to be produced (3.4 mg cmyr/100 ml culture). Myrosinase activity was determined by mixing substrate and enzyme and determining glucose release. Optimum pH and temperature were determined to be pH 6.0 and 25 °C for the Ni-NTA purified protein. The kinetic parameters of the purified myrosinase were determined using sinigrin as a substrate. K

Indexed as

CitrobacterGlucosinolatesCloning, MolecularGlycoside HydrolasesSubstrate SpecificityGlucosinolatesGlycoside HydrolasesthioglucosidaseBiotransformationCitrobacterGlucosinolateMyrosinase

Identifiers

PMID35031980
OpenAlexW4206393344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.